These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22542316)

  • 1. Oncology biomarkers: discovery, validation, and clinical use.
    Heckman-Stoddard BM
    Semin Oncol Nurs; 2012 May; 28(2):93-8. PubMed ID: 22542316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers: an overview for oncology nurses.
    Richmond ES; Dunn D
    Semin Oncol Nurs; 2012 May; 28(2):87-92. PubMed ID: 22542315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ; Waybright TJ; Veenstra TD
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biomarkers in cancer clinical trials.
    Reid M; Yasko J
    Semin Oncol Nurs; 2012 May; 28(2):116-21. PubMed ID: 22542319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of cancer biomarker profiling.
    Bensalah K; Montorsi F; Shariat SF
    Eur Urol; 2007 Dec; 52(6):1601-9. PubMed ID: 17919807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating biomarkers in clinical trials.
    Buyse M; Michiels S; Sargent DJ; Grothey A; Matheson A; de Gramont A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):171-82. PubMed ID: 21405968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical data processing in clinical proteomics.
    Smit S; Hoefsloot HC; Smilde AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):77-88. PubMed ID: 18033744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. So, you want to look for biomarkers (introduction to the special biomarkers issue).
    LaBaer J
    J Proteome Res; 2005; 4(4):1053-9. PubMed ID: 16083254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, validation, and clinical implementation of tumor-associated biomarkers to improve therapy concepts, survival, and quality of life of cancer patients: tasks of the Receptor and Biomarker Group of the European Organization for Research and Treatment of Cancer.
    Schmitt M; Harbeck N; Daidone MG; Brynner N; Duffy MJ; Foekens JA; Sweep FC
    Int J Oncol; 2004 Nov; 25(5):1397-406. PubMed ID: 15492831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.
    Sogno I; Conti M; Consonni P; Noonan DM; Albini A
    Rapid Commun Mass Spectrom; 2012 May; 26(10):1213-8. PubMed ID: 22499197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers as surrogate endpoints in cancer trials.
    Dunn BK; Akpa E
    Semin Oncol Nurs; 2012 May; 28(2):99-108. PubMed ID: 22542317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic brain injury biomarkers: from pipeline to diagnostic assay development.
    Oli MW; Hayes RL; Robinson G; Wang KK
    Methods Mol Biol; 2009; 566():293-302. PubMed ID: 20058179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for lung cancer: clinical uses.
    Greenberg AK; Lee MS
    Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trials.
    Shi Q; Mandrekar SJ; Sargent DJ
    Scand J Gastroenterol; 2012 Mar; 47(3):356-62. PubMed ID: 22181041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matrix approach to guide IHC-based tissue biomarker development in oncology drug discovery.
    Smith NR; Womack C
    J Pathol; 2014 Jan; 232(2):190-8. PubMed ID: 24030847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.